Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Intramuscular dexmedetomidine can be used for pediatric sedation without requiring intravenous access and has advantages for electroencephalography by inducing natural sleep pathway, but only a limited number of studies compared the efficacy of intramuscular dexmedetomidine with oral chloral hydrate.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Aims</h3><p>To compare the efficacy and safety of intramuscular dexmedetomidine and oral chloral hydrate used for sedation during electroencephalography in pediatric patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>We reviewed the medical records of pediatric patients who underwent sedation for electroencephalography between January 2015 and December 2016. Initial doses of dexmedetomidine and chloral hydrate were 3 mcg/kg and 50 mg/kg, respectively; second doses (1 mcg/kg and 50 mg/kg, respectively) were administered if adequate sedation was not achieved. Demographic data, time of sedative administration, time of sedation and awakening, and time of arrival at recovery room and discharge were analyzed.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Out of a total of 1239 patients, 125 patients had received dexmedetomidine and 1114 had received chloral hydrate. After 1:1 propensity score matching, the dexmedetomidine and chloral hydrate groups each had 118 patients. Testing completion rate with a single dose of medication was higher in the dexmedetomidine group (91.5 vs. 71.2%; mean difference [95% CI] 20.3 [10.8‐29.9]; P < 0.0001; Pearson chi square value = 16.09). Sedation onset time was shorter in the dexmedetomidine group as well (16.6 ± 13.0 min vs. 41.5 ± 26.8 min; mean difference [95% CI] 24.8 [19.1‐30.6]; P < 0.0001; T = 8.27). On the contrary, the duration of recovery was longer in the dexmedetomidine group (35.5 ± 40.2 min vs. 18.5 ± 30.7 min; mean difference [95% CI] 18.6 [8.8‐28.5]; P = 0.0002; T = ‐2.82). Total residence time was not significantly different between the two groups (125.8 ± 40.6 min vs. 122.1 ± 42.2 min, mean difference [95% CI] 5.21 [6.1‐16.5], P = 0.3665 T = 0.04).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Intramuscular dexmedetomidine showed higher sedation success rate and shorter time to achieving the desired sedation level compared with oral chloral hydrate, and thus may be an effective alternative for oral chloral hydrate in pediatric patients requiring sedation for electroencephalography.</p></section>

EEG response of dexmedetomidine during drug induced sleep endoscopy

Electroencephalography Study of Patients Sedated with Dexmedetomidine in Intensive Care Unit

Effects of Dexmedetomidine on the Electrocorticography Monitoring in Patients Undergoing Epilepsy Surgery

Determination of the effective dose of dexmedetomidine to achieve loss of consciousness during anesthesia induction

A comparison of dexmedetomidine versus propofol during drug-induced sleep endoscopy in sleep apnea patients

Comparison of intranasal dexmedetomidine alone and dexmedetomidine-chloral hydrate combination sedation for electroencephalography in children: A large retrospective cohort study and propensity score-matched analysis

Depth of sedation with dexmedetomidine increases transcranial magnetic stimulation-evoked potential amplitude non-linearly

Oral Delivered Dexmedetomidine Promotes and Consolidates Non-rapid Eye Movement Sleep via Sleep-Wake Regulation Systems in Mice

Dexmedetomidine Induces Low Patient State Indices While Preventing the Development of Postoperative Delirium in Older Patients Undergoing General Anesthesia - A Secondary Analysis of a Randomized Controlled Trial (NEUPRODEX)

Efficacy of Combination Therapy with Dexmedetomidine for Benzodiazepines-Induced Disinhibition During Endoscopic Retrograde Cholangiopancreatography.

Effects of dexmedetomidine on emergence delirium and electroencephalogram during the recovery period in older patients undergoing lower limb orthopedic surgery: A randomized, double-blind, placebo-controlled clinical trial

Relationship between the patient state index and sedation scale during dexmedetomidine sedation during spinal anesthesia

A Comparative Study on Efficacy and Safety of Propofol Versus Dexmedetomidine in Sleep Apnea Patients Undergoing Drug-Induced Sleep Endoscopy: A CONSORT-Prospective, Randomized, Controlled Clinical Trial

Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine

Identifying the Pathophysiological Traits of Obstructive Sleep Apnea During Dexmedetomidine Sedation.

Intranasal dexmedetomidine sedation for EEG in children with autism spectrum disorder

Brain functional connectivity differentiates dexmedetomidine from propofol and natural sleep

Influence of Dexmedetomidine on Sedation

Intramuscular dexmedetomidine and oral chloral hydrate for pediatric sedation for electroencephalography: A propensity score‐matched analysis

Effect of Dexmedetomidine on the Postoperative Cognitive Function of Patients Undergoing Radical Resection of Esophageal Cancer

Advances in the use of dexmedetomidine during the perioperative period to improve postoperative sleep quality in patients undergoing surgery